aggrego Conference Hub

Carefully curated news articles, video interviews, and podcasts providing live, in-depth coverage of oncology meetings, conferences, and congresses within the United States and abroad.
Top Stories
Early, Encouraging Data for Glioblastoma Treatment Reported at ASCO

All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham have exceeded both their median and expected progression-

Medical Xpress
2w ago
'Unprecedented' 100% of First 14 Untreated Patients With Rectal Cancer Respond to PD-1 Blocker Dostarlimab-gxly

In a study of patients with locally advanced mismatch repair–deficient (dMMR) rectal cancer, 6 months of treatment with the anti–PD-1 agent dostarlimab-gxly alone led to clinical complete responses

The ASCO Post
3w ago
Momelotinib Bests Danazol in Symptomatic, Anemic Myelofibrosis

Momelotinib proved superior to danazol for key outcomes in a phase 3 trial of patients with symptomatic and anemic myelofibrosis.

Cancer Therapy Advisor
1w ago